Clinical Trials on Esophageal Neoplasm Metastatic in Switzerland

Total 2075 results

Matthias Guckenberger

Recruiting

Single-isocenter SBRT vs. Multiple-isocenter SBRT for Multiple Extracranial Metastases

Metastatic Cancer

Switzerland
University of Zurich

Unknown

Long-term Outcome of HER2-amplified Metastatic Breast Cancer: A Retrospective Analysis

Breast Cancer | Metastatic Neoplasm | ERBB2

Switzerland
University Hospital, Basel, Switzerland

Not yet recruiting

Safety and Modulation of Adaptive Immunity by Iscador® Qu Viscum Album Extract in Patients With Advanced, Recurrent or Metastatic Cancers Treated With Immune Checkpoint Inhibitors (ISCA-CHECK)

Advanced Solid Tumor

Switzerland
Insel Gruppe AG, University Hospital Bern

Recruiting

Conebeam CT-based Online Adaptive Radio-Therapy for Esophageal Cancer (ARTEC) (ARTEC)

Esophageal Cancer

Switzerland
Novartis Pharmaceuticals

Completed

PI3K Inhibitor BYL719 in Combination With the HSP90 Inhibitor AUY922 in Patients With Advanced or Metastatic Gastric Cancer

Stomach Neoplasms Esophageal Neoplasms Metastatic Gastric Cancer Mutated PI3KCA Protein Overexpressed HER2 Protein

Taiwan, Switzerland, Korea, Republic of, Germany, United States, Japan
David Palma
London Health Sciences Centre; Amsterdam University Medical Centre, VUmc Site; British Columbia Cancer - Centre for the North and other collaborators

Active, not recruiting

Stereotactic Ablative Radiotherapy for Comprehensive Treatment of 4-10 Oligometastatic Tumors (SABR-COMET 10)

Metastatic Tumors

United Kingdom, Canada, Switzerland, Netherlands, Australia
Swiss Group for Clinical Cancer Research

Completed

Cetuximab, Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery

Esophageal Cancer

Switzerland
AO Innovation Translation Center
AO Foundation, AO Spine

Recruiting

Metastatic Tumor Research and Outcomes Network (MTRON)

Metastatic Spine Tumor

United States, Canada, Hungary, Australia, Germany, Italy, Japan, Netherlands, Singapore, Switzerland
Centre Hospitalier Universitaire Vaudois

Unknown

Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery

Colorectal Cancer | Metastatic Cancer

Switzerland
University of Zurich

Unknown

Associating Liver Partition With Portal Vein Ligation for Staged Hepatectomy (ALPPS) vs. Two-Stage Hepatectomy (TSH) for Marginally Resectable Colorectal Liver Metastases (CRLM) (ALPPSforCRLM)

Liver Diseases | Liver Neoplasms | Hepatectomy | Surgery | Secondary Malignant Neoplasm of Liver | Colon Cancer Liver Metastases | Malignant Neoplasm of Large Intestine Metastatic to Liver

Switzerland
European Organisation for Research and Treatment...

Terminated

Adjuvant Radiation Therapy in Treating Patients With Brain Metastases

Metastatic Cancer

France, Finland, United Kingdom, Belgium, Israel, Germany, Switzerland, Netherlands, Turkey, Italy, Portugal, Spain, Latvia
Dan Azagury

Terminated

Perioperative Nutrition in Upper Gastrointestinal (GI) Cancer Surgery

Stomach Neoplasms | Esophageal Neoplasms

Switzerland
University of Zurich

Active, not recruiting

Clinical Trial Comparing Dose-intensified SBRT With Conventional Radiation Therapy for Spinal Metastases (DOSIS RCT)

Spinal Metastasis

Switzerland
Dromain Clarisse

Unknown

Pre-operative MRI of Esophagus Cancer (STIRMCO)

Diagnoses Disease | Esophagus Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgery

Esophageal Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer

Esophageal Cancer

Switzerland
Luzerner Kantonsspital

Recruiting

Role of Intrapulmonary Lymph Nodes in Patients With NSCLC and Visceral Pleural Invasion

Lung Cancer | Lymph Node Metastasis

Switzerland
University Hospital Inselspital, Berne
Swiss National Science Foundation

Completed

USPIO-enhanced and Diffusion-weighted MRI for the Detection of Pelvic Lymph Node Metastases

Prostate Cancer | Bladder Cancer

Switzerland
European Organisation for Research and Treatment...

Terminated

Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma

Metastatic Cancer | Intraocular Melanoma

Switzerland, Italy, United Kingdom, Poland
Centre Hospitalier Universitaire Vaudois

Active, not recruiting

Analysis of the Modulation of the Tumor Microenvironment by MK-3475 (Pembrolizumab) Using a Systems Biology Approach (PEMSYS)

Metastatic Melanoma Naive to Immune Therapy in Metastatic Setting

Switzerland
Cantonal Hospital of St. Gallen
University of Zurich

Unknown

Reversibility of Dysmotility After Gastric Banding

Ineffective Motility | Diffuse Esophageal Spasms | Achalasia-Like Dysmotility

Switzerland
Kantonsspital Graubuenden
Swiss Group for Clinical Cancer Research

Completed

SBRT for Oligometastatic Lymph Node Recurrence in Prostate Cancer: a Single Institution Experience

Prostate Cancer | Prostate Cancer Recurrent | Lymph Node Metastases

Switzerland
Terumo Europe N.V.

Completed

Holmium-166 Retrospective Collection of Real-World Data (RECORD)

Hepatocellular Carcinoma | Metastatic Cancer

Netherlands, Germany, Switzerland, Belgium, Spain, Portugal, Italy
Kantonsspital Liestal
University of Bern

Completed

Esophageal Stump Washout

Esophageal Cancer | Gastrooesophageal Cancer

Switzerland
Cantonal Hospital of St. Gallen
University Hospital, Geneva; University Hospital Muenster; Stanford University; University of Toronto and other collaborators

Recruiting

Microsurgical Resection of Intramedullary Spinal Cord Metastases

Spinal Cord Neoplasms | Radiotherapy; Complications | Functional Outcome | Spinal Cord Metastasis | Spinal Cord Tumor Malignant Intramedullary

Switzerland
University of Zurich

Unknown

Observational Field Study of Acute Esophageal Food Bolus Impaction by Mean Esophageal Manometry and 24h-pH-monitoring

Esophageal Motility Disorders

Switzerland
Centre Hospitalier Universitaire Vaudois

Recruiting

Irradiation of Melanoma in a Pulse (IMPulse)

Metastasis From Malignant Melanoma of Skin (Diagnosis)

Switzerland
Spital STS AG
Department of Medicine, Spital STS AG Thun

Completed

Esophageal Dysmotility and Dilatation After Laparoscopic Gastric Banding

Esophageal Motility Disorders

Switzerland
University Ghent
University Hospital, Geneva

Active, not recruiting

PEACE V: Salvage Treatment of OligoRecurrent Nodal Prostate Cancer Metastases (STORM)

Prostate Cancer | Metastatic Cancer | Prostate Cancer Metastatic | Oligometastatic Cancer

Norway, Spain, Belgium, Switzerland, Australia, Italy
AstraZeneca

Completed

Gastroesophageal Reflux Disease (GERD) Segmentation: Document How Swiss General Practitioners (GPs) Allocate Their GERD Patients to the Three GERD Patient Segments

GERD

Switzerland
University of Bern
Northwestern University Feinberg School of Medicine

Completed

Eosinophilic Esophagitis: Influence of Dilation on Dysphagia and Inflammation

Eosinophilic Esophagitis | Esophageal Stenosis | Esophageal Dilation | Esophageal Dilatation

Switzerland
Karolinska Institutet

Completed

Microwave Ablation Versus Resection for Resectable Colorectal Liver Metastases (MAVERRIC)

Neoplasm Metastasis

Netherlands, Sweden, Switzerland
Ipsen

Terminated

Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.

Gastric Cancer | Colorectal Cancer | Bone Cancer | Squamous Cell Carcinoma of the Head and Neck | Advanced Cancer | Recurrent Disease | Pancreatic Ductal Adenocarcinoma | Metastatic Tumours

United States, France, Belgium, Switzerland, Netherlands
University of Lausanne Hospitals
University Hospital, Zürich; Cantonal Hospital of St. Gallen

Completed

[18F]-AZAFOL AS POSITRON EMISSION TOMOGRAPHY (PET) TRACER in FR Positive Cancer Imaging

Metastatic Ovarian Cancer | Metastatic Cancer Lung

Switzerland
University of Zurich

Completed

Impact of Preoperative Chemotherapy on Complications and Regeneration After Resection of Colorectal Liver Metastases

Colorectal Liver Metastases

Switzerland
University Hospital, Basel, Switzerland

Recruiting

Circulating Tumor Cells (CTC) in Cancer

Cancer

Switzerland
Centre Hospitalier Universitaire Vaudois

Recruiting

Respiratory and Hemodynamic Implications of Endoscopic Myotomy of the Esophagus and Stomach

Gastroparesis | Esophageal Achalasia

Switzerland
University of Zurich

Completed

Structure and Function of the Gastro-esophageal Junction

Gastroesophageal Reflux Disease

Switzerland
Amal Therapeutics
Boehringer Ingelheim

Active, not recruiting

Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer (KISIMA-01)

Metastatic Colorectal Cancer | Colorectal Cancer | Liver Metastasis Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal Cancer | MSS

United States, Belgium, Switzerland, Germany
Amsterdam UMC

Recruiting

Prospective Endoscopic Follow-up of Patients With Submucosal and High Risk Mucosal Esophageal Adenocarcinoma (PREFER)

Barrett Esophagus | Submucosal Esophageal Adenocarcinoma | High-risk Mucosal Esophageal Adenocarcinoma

Netherlands, Belgium, Australia, United Kingdom, Germany, Switzerland
University of Aarhus
Centre Leon Berard; University College London Hospitals; Aarhus University Hospital and other collaborators

Recruiting

PROton Versus Photon Therapy for Esophageal Cancer - a Trimodality Strategy (PROTECT)

Esophageal Cancer | Radiotherapy | Proton Therapy | Side Effect

United Kingdom, France, Belgium, Denmark, Germany, Italy, Netherlands, Switzerland
Academisch Medisch Centrum - Universiteit van Amsterdam...

Unknown

Outcomes of Endoscopically Resected High-risk Mucosal and Low- and High-risk Submucosal Adenocarcinoma Arising in Barrett's Esophagus

Barrett Esophagus | Adenocarcinoma Esophagus | Submucosal Esophageal Adenocarcinoma | High-risk Mucosal Esophageal Adenocarcinoma

France, United Kingdom, Belgium, Germany, Switzerland, Australia, Netherlands
University of Zurich
AstraZeneca

Completed

Study to Assess Management Strategies for the Use of Esomeprazole (Nexium) in Helicobacter Pylori Infected Patients

Gastroesophageal Reflux Disease (GERD)

Switzerland
University of Zurich

Completed

Measurement of Gastric Secretion by MRI Under Inhibition by ProtonPump Inhibitors in Healthy Subjects & in GERD Patients

Gastroesophageal Reflux Disease | Healthy Volunteers

Switzerland
Incyte Biosciences International Sàrl

Completed

A Phase 1/2, Open-Label, Dose-Escalation, Safety Study of INCAGN01949 in Subjects With Advanced or Metastatic Solid Tumors

Metastatic Cancer | Advanced Malignancies

United States, United Kingdom, Spain, Switzerland
Prof Urs Zingg

Recruiting

High Resolution Manometry After Partial Fundoplication for Gastro-oesophageal Reflux

Gastroesophageal Reflux | Esophageal Motility Disorders | Upper Gastrointestinal Disorder

Switzerland
University Hospital, Basel, Switzerland

Completed

DOTA-TOC in Metastasized Neuroendocrine Tumors

Neuroendocrine Tumors

Switzerland
University of Bern
University of Zurich; Swiss National Science Foundation; Centre Hospitalier Universitaire... and other collaborators

Not yet recruiting

Deprescribing Inappropriate Proton Pump Inhibitors (DROPIT)

Reflux Disease | Inappropriate Prescribing | Proton Pump Inhibitors

Switzerland
University of Zurich

Completed

Ipilimumab-induced Lung Toxicity: Observational Study (Ipi-Lu-Tox)

Metastatic Melanoma

Switzerland
University of Zurich
M.D. Anderson Cancer Center; The Netherlands Cancer Institute

Recruiting

Standardized Clinical Assessment of Patients With Leptomeningeal Metastasis (NANO-LM)

Leptomeningeal Disease | Leptomeningeal Metastasis | Leptomeningeal Neoplasms | Leptomeningeal Cancer

United States, Switzerland, Netherlands

Clinical Trials on Esophageal Neoplasm Metastatic in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Pakistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations